Axcella

0 followers

‌

Axcella is designing and developing novel endogenous metabolic modulator compositions to safely reprogram metabolic dysregulation

Industries

Headquarters

Stage

Employees

Links

Org chart

View full screen

Bill Hinshaw

President & CEO

Bill Hinshaw

Collapse

Margaret Koziel

SVP & Chief Medical Officer

Geoffrey von Maltzahn

Co-Founder, VP Discovery (2009-2013)

Karim Azer

VP, Head of Platform & Discovery

Catherine Sohn, Pharm.D.

Board Member

Thomas Hanlon

VP, Head of CMC

MIRANDA KOCHER

HR Operations Consultant

Ralph Yamamoto

Senior Director of Analytical Science and Technology

Saravanapriah(Priah) Nadarajan

Scientist

Sergey (Serge) Fridrikh

Senior Scientist, Computational Biology

Rui Rosa

Manager laboratory and facilities

Dan Kirby

SVP, Strategic Operations

Teams

View all

Board of Directors

11 members

CEO and Executive Team

3 members

Leadership Team

3 members

Discover similar companies

Coherus BioSciences

5 followers

Agilent Technologies

60 followers

Regeneron

77 followers

Verve Therapeutics

53 followers

Biogen

91 followers